KymaThera
a provider of precision medicines for genetically defined diseases
Amount raised
$80M
Round
Series B
Date raised
October 1, 2026
Founded
—
CompanyKymaThera
IndustryBiotechnology
LocationSan Diego, CA, United States
InvestorsAlta Partners
Websitekymathera.com
Leadership
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About KymaThera
a provider of precision medicines for genetically defined diseases
- How much did KymaThera raise?
- KymaThera raised $80M in a Series B round on October 1, 2026. Investors include Alta Partners.
- Who runs KymaThera?
- Rob Kania (Chief Executive Officer) is listed as KymaThera's officer.
- Where is KymaThera based?
- KymaThera is based in San Diego, CA, United States.